| # | Drug | Count |
|---|---|---|
| 0 | RUXOLITINIB | 4 |
| 1 | HUMAN C1-ESTERASE INHIBITOR | 3 |
| 2 | MACITENTAN | 3 |
| 3 | ROPEGINTERFERON ALFA-2B | 3 |
| 4 | APIXABAN | 2 |
| 5 | CARVEDILOL | 2 |
| 6 | CETIRIZINE | 2 |
| 7 | CETIRIZINE HYDROCHLORIDE | 2 |
| 8 | FUROSEMIDE | 2 |
| 9 | HYDROXYUREA | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ROPEGINTERFERON ALFA-2B | 3 | 0.0016 |
| 1 | QUIZARTINIB | 1 | 0.0014 |
| 2 | CHOLESTERINUM | 1 | 0.0009 |
| 3 | DOBUTAMINE HYDROCHLORIDE | 1 | 0.0008 |
| 4 | MOMELOTINIB | 1 | 0.0007 |
| 5 | DEXMEDETOMIDINE HYDROCHLORIDE | 1 | 0.0003 |
| 6 | SUCROFERRIC OXYHYDROXIDE | 1 | 0.0003 |
| 7 | SOTATERCEPT-CSRK | 2 | 0.0003 |
| 8 | TENAPANOR HYDROCHLORIDE | 1 | 0.0003 |
| 9 | DOPAMINE HYDROCHLORIDE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 4 |
| 1 | Janus Kinase Inhibitor [EPC] | 4 |
| 2 | Kinase Inhibitor [EPC] | 4 |
| 3 | Endothelin Receptor Antagonist [EPC] | 3 |
| 4 | Interferon alfa-2b [EPC] | 3 |
| 5 | Antimetabolite [EPC] | 2 |
| 6 | Atypical Antipsychotic [EPC] | 2 |
| 7 | Azole Antifungal [EPC] | 2 |
| 8 | Factor Xa Inhibitor [EPC] | 2 |
| 9 | Loop Diuretic [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon alfa-2b [EPC] | 3 | 0.0016 |
| 1 | Ectoparasiticide [EPC] | 1 | 0.0003 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 3 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 4 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 6 | Iron Chelator [EPC] | 1 | 0.0000 |
| 7 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Janus Kinase Inhibitor [EPC] | 4 | 0.0000 |
| 9 | Polyene Antifungal [EPC] | 1 | 0.0000 |